Benzinga | Dec 3, 2021 05:33AM EST

Longeveron on Thursday Was Granted FDA Orphan Drug Designation for Treatment of Hypoplastic Left Heart Syndrome

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=849521